International Conference on Neuroscience and Neurodegenerative Biomarkers
(ICNNB-26)

27th December 2026 || Chandigarh - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Neuroscience and Neurodegenerative Biomarkers (ICNNB), scheduled to be held on 27th December 2026 in Chandigarh, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Neuroscience.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Alzheimer's Research
    This track focuses on the latest findings in Alzheimer's disease research, emphasizing novel therapeutic approaches and interventions. Participants will explore cutting-edge studies that highlight the role of biomarkers in early diagnosis and treatment efficacy. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Neurodegenerative Disease Mechanisms
    This session will delve into the underlying biological mechanisms that contribute to neurodegenerative diseases. Discussions will include genetic, environmental, and lifestyle factors that influence disease progression. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 03 – Biomarkers in Neurodegeneration
    This track aims to present recent advancements in the identification and validation of biomarkers for neurodegenerative diseases. Researchers will share insights on how these biomarkers can enhance diagnostic accuracy and patient stratification. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Neuroinflammation and Neurodegeneration
    This session will explore the relationship between neuroinflammation and the progression of neurodegenerative disorders. Presentations will focus on the role of inflammatory pathways and potential therapeutic targets. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 05 – Cognitive Decline and Biomarker Correlation
    This track will investigate the correlation between cognitive decline and various neurodegenerative biomarkers. Researchers will present data on how these biomarkers can predict cognitive impairment and disease trajectory. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 06 – Neuroimaging Techniques in Biomarker Discovery
    This session will highlight the role of advanced neuroimaging techniques in the discovery and validation of neurodegenerative biomarkers. Participants will discuss the integration of imaging data with clinical outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 07 – Translational Research in Neuroscience
    This track will focus on the translation of basic neuroscience research into clinical applications for neurodegenerative diseases. Emphasis will be placed on collaborative efforts between researchers and clinicians. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 08 – Psychosocial Factors in Neurodegenerative Diseases
    This session will examine the psychosocial factors that influence the experience and management of neurodegenerative diseases. Discussions will include the impact of mental health on disease progression and patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 09 – Innovative Therapeutics for Neurodegeneration
    This track will showcase innovative therapeutic strategies being developed for the treatment of neurodegenerative diseases. Presentations will cover pharmacological and non-pharmacological interventions. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Patient-Centered Approaches in Neuroscience
    This session will focus on the importance of patient-centered approaches in the management of neurodegenerative diseases. Researchers will discuss strategies for involving patients in research and treatment decision-making. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 11 – Future Directions in Neurodegenerative Biomarkers
    This track will explore future directions and emerging trends in the field of neurodegenerative biomarkers. Participants will engage in discussions about the potential for personalized medicine and novel diagnostic tools. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228